CDx

Careers

FR

Can Microsampling Devices Coupled with Intact Mass High-Resolution Mass Spectrometry Improve M-Protein Monitoring and Simplify Minimal Residual Disease Assessment in Multiple Myeloma?

Affiches Nov 10, 2025

Oncologie

|

Spectrométrie de masse

November 10, 2025

Can Microsampling Devices Coupled with Intact Mass High-Resolution Mass Spectrometry Improve M-Protein Monitoring and Simplify Minimal Residual Disease Assessment in Multiple Myeloma?

WRIB 2

Understanding Protein Normalization: A Case Study in PBMC Fit-for-Purpose Validation by MS

JBF 1

Challenging Hybrid Affinity Approach: Streamlined Total Antibody Quantitation with Uncompromised Sensitivity

Patient-Centric Measurement of M-Protein Using High-Resolution Intact Mass Spectrometry

CellCarta has the multi-modal capabilities, scientific depth, and harmonized global footprint needed to advance even the most complex programs in precision medicine.